GENE ONLINE|News &
Opinion
Blog

Exelixis
FDA Clears Exelixis, Sairopa’s SIRPα Antibody For Solid Tumor Trial
2023-02-14
Exelixis, Cybrexa Pen $700 Million Deal Over Peptide-Drug Conjugate
2022-11-02
FDA Accepts Opdivo, Cabometyx Combo’s Priority Review Applications
2020-10-21
LATEST
Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS
2023-03-24
Moderna Injects $76 Million To Kickstart Lipid Nanoparticle Delivery Partnership With Generation Bio
2023-03-24
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
2023-03-23
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
Biohaven Licenses TYK2/JAK1 Dual Inhibitor From China’s Highlight In $970 Million Pact
2023-03-23
FDA Extends Approval Of Regeneron’s Evkeeza For Inherited High Cholesterol
2023-03-23
Launching an Innovative Product, PlaClin-M, for Safe Environments in the Pandemic Era.
2023-03-23
Scroll to Top